144 related articles for article (PubMed ID: 1113309)
21. [Trends in the immunologic studies of tumors in man].
Noda M
Saishin Igaku; 1971 Sep; 26(9):1750-4. PubMed ID: 4938186
[No Abstract] [Full Text] [Related]
22. Immunologic interreactions in neoplastic diseases. A brief review.
Kushnick T
Clin Pediatr (Phila); 1971 Jul; 10(7):372-6. PubMed ID: 4933466
[No Abstract] [Full Text] [Related]
23. Immunodeficiency and cancer: mechanisms involved.
Cottier H; Hess MW; Wälti ER
Schweiz Med Wochenschr; 1986 Aug; 116(34):1119-26. PubMed ID: 3532311
[TBL] [Abstract][Full Text] [Related]
24. An insight into cancer immunology and immunotherapy.
Thompson RB
Prog Clin Pathol; 1975; 6():159-76. PubMed ID: 1105670
[No Abstract] [Full Text] [Related]
25. Editorial: Immunity and oncogenesis.
Danilevicius Z
JAMA; 1974 Nov; 230(8):1179. PubMed ID: 4479549
[No Abstract] [Full Text] [Related]
26. [Immunological surveillance and spontaneous carcinogenesis].
Salomon JC
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):669-75. PubMed ID: 4559234
[No Abstract] [Full Text] [Related]
27. The stromal reaction of tumors: an expression of immune surveillance.
Ioachim HL
J Natl Cancer Inst; 1976 Sep; 57(3):465-75. PubMed ID: 789905
[No Abstract] [Full Text] [Related]
28. [Immunology of cancer].
Grundmann E
Langenbecks Arch Chir; 1971 Dec; 329():264-75. PubMed ID: 4144610
[No Abstract] [Full Text] [Related]
29. Immune stimulation-inhibition of experimental cancer metastasis.
Fidler IJ
Cancer Res; 1974 Mar; 34(3):491-8. PubMed ID: 4812256
[No Abstract] [Full Text] [Related]
30. Immunosuppression and cancer.
Vandeputte M
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):677-83. PubMed ID: 4340542
[No Abstract] [Full Text] [Related]
31. How efficient is immunological surveillance against cancer and why does it fail?
Laroye GJ
Lancet; 1974 Jun; 1(7866):1097-1100. PubMed ID: 4135256
[No Abstract] [Full Text] [Related]
32. Letter: Transfer-factor therapy in multiple sclerosis.
Jersild C; Platz P; Thomsen M; Hansen GS; Svejgaard A; Dupont B; Fog T; Ciongoli AK; Grob P
Lancet; 1973 Dec; 2(7842):1381-2. PubMed ID: 4128065
[No Abstract] [Full Text] [Related]
33. [Immunosuppression and cancer: clinical aspects].
Brouet JC
Bull Cancer; 1983; 70(1):40-6. PubMed ID: 6839033
[TBL] [Abstract][Full Text] [Related]
34. [Immunotherapy of neoplasms].
Trepel F
Med Klin; 1971 Feb; 66(7):222-9. PubMed ID: 4324109
[No Abstract] [Full Text] [Related]
35. Cell-mediated immunity.
Valentine FT; Lawrence HS
Adv Intern Med; 1971; 17():51-93. PubMed ID: 4147307
[No Abstract] [Full Text] [Related]
36. [Immunotherapy of cancer].
Lascano FD; Mazzei JA; Estevez ME
Prensa Med Argent; 1971 Mar; 58(2):75-91. PubMed ID: 4103879
[No Abstract] [Full Text] [Related]
37. [The immunotherapeutic approaches to the management of leukemia and neoplasms].
Leu TP
Zhonghua Yi Xue Za Zhi; 1974 May; 5():310-4. PubMed ID: 4211699
[No Abstract] [Full Text] [Related]
38. Transfer of tumor immunity with ribonucleic acid.
Deckers PJ; Pilch YH
Surg Forum; 1970; 21():124-6. PubMed ID: 5514705
[No Abstract] [Full Text] [Related]
39. Predictive oncology. 3.
Bierman HR
Int Surg; 1973; 58(11):768-73. PubMed ID: 4584400
[No Abstract] [Full Text] [Related]
40. Editorial: Transfer-factor therapy of immunodeficiencies.
Polmar SH
N Engl J Med; 1973 Dec; 289(26):1420-1. PubMed ID: 4127762
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
